Clinical Trial Update: Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a vaccine in newly diagnosed or recurrent low-grade glioma, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Diffuse Astrocytoma
• Mixed Glioma
• Oligoastrocytoma
• Oligodendroglioma

Drugs mentioned

• vaccine for patients with newly diagnosed or recurrent low-grade glioma

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Adult Diffuse Astrocytoma, Adult Mixed Glioma | Phase 2 | Status: COMPLETED | Results posted: 2020-11-04